ReP USP - Resultado da busca

Artigo de periodico
Can the evidence-based use of probiotics (Notably Saccharomyces boulardii CNCM I-745 and Lactobacillus rhamnosus GG) mitigate the clinical effects of antibiotic-associated dysbiosis? (2024)
Waitzberg, Dan Linetzky ; Guarner, Francisco; Hojsak, Iva; Ianiro, Gianluca; Polk, D. Brent; Sokol, Harry
Fonte: Advances in therapy. Unidade: FM
Assuntos: ANTIBIÓTICOS, DIARREIA, BIOTA INTESTINAL, PROBIÓTICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WAITZBERG, Dan Linetzky et al. Can the evidence-based use of probiotics (Notably Saccharomyces boulardii CNCM I-745 and Lactobacillus rhamnosus GG) mitigate the clinical effects of antibiotic-associated dysbiosis?. Advances in therapy, v. 41, n. 3, p. 901-914, 2024Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/76934. Acesso em: 01 dez. 2025.
APA
Waitzberg, D. L., Guarner, F., Hojsak, I., Ianiro, G., Polk, D. B., & Sokol, H. (2024). Can the evidence-based use of probiotics (Notably Saccharomyces boulardii CNCM I-745 and Lactobacillus rhamnosus GG) mitigate the clinical effects of antibiotic-associated dysbiosis? Advances in therapy, 41( 3), 901-914. doi:10.1007/s12325-024-02783-3
NLM
Waitzberg DL, Guarner F, Hojsak I, Ianiro G, Polk DB, Sokol H. Can the evidence-based use of probiotics (Notably Saccharomyces boulardii CNCM I-745 and Lactobacillus rhamnosus GG) mitigate the clinical effects of antibiotic-associated dysbiosis? [Internet]. Advances in therapy. 2024 ; 41( 3): 901-914.[citado 2025 dez. 01 ] Available from: https://observatorio.fm.usp.br/handle/OPI/76934
Vancouver
Waitzberg DL, Guarner F, Hojsak I, Ianiro G, Polk DB, Sokol H. Can the evidence-based use of probiotics (Notably Saccharomyces boulardii CNCM I-745 and Lactobacillus rhamnosus GG) mitigate the clinical effects of antibiotic-associated dysbiosis? [Internet]. Advances in therapy. 2024 ; 41( 3): 901-914.[citado 2025 dez. 01 ] Available from: https://observatorio.fm.usp.br/handle/OPI/76934
Artigo de periodico
Pharyngeal Reconstruction Methods to Reduce the Risk of Pharyngocutaneous Fistula After Primary Total Laryngectomy: A Scoping Review (2023)
Sanabria, Alvaro ; Olivera, Maria Paula; Chiesa Estomba, Carlos; Hamoir, Marc; Kowalski, Luiz Paulo ; Lopez, Fernando; Makitie, Antti; Robbins, K. Thomas; Rodrigo, Juan Pablo; Piazza, Cesare
Fonte: Advances in therapy. Unidade: FM
Assuntos: PROCEDIMENTOS CIRÚRGICOS RECONSTRUTIVOS, FÍSTULA, DOENÇAS FARÍNGEAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANABRIA, Alvaro et al. Pharyngeal Reconstruction Methods to Reduce the Risk of Pharyngocutaneous Fistula After Primary Total Laryngectomy: A Scoping Review. Advances in therapy, v. 40, n. 9, p. 3681-3696, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/55937. Acesso em: 01 dez. 2025.
APA
Sanabria, A., Olivera, M. P., Chiesa Estomba, C., Hamoir, M., Kowalski, L. P., Lopez, F., et al. (2023). Pharyngeal Reconstruction Methods to Reduce the Risk of Pharyngocutaneous Fistula After Primary Total Laryngectomy: A Scoping Review. Advances in therapy, 40( 9), 3681-3696. doi:10.1007/s12325-023-02561-7
NLM
Sanabria A, Olivera MP, Chiesa Estomba C, Hamoir M, Kowalski LP, Lopez F, Makitie A, Robbins KT, Rodrigo JP, Piazza C. Pharyngeal Reconstruction Methods to Reduce the Risk of Pharyngocutaneous Fistula After Primary Total Laryngectomy: A Scoping Review [Internet]. Advances in therapy. 2023 ; 40( 9): 3681-3696.[citado 2025 dez. 01 ] Available from: https://observatorio.fm.usp.br/handle/OPI/55937
Vancouver
Sanabria A, Olivera MP, Chiesa Estomba C, Hamoir M, Kowalski LP, Lopez F, Makitie A, Robbins KT, Rodrigo JP, Piazza C. Pharyngeal Reconstruction Methods to Reduce the Risk of Pharyngocutaneous Fistula After Primary Total Laryngectomy: A Scoping Review [Internet]. Advances in therapy. 2023 ; 40( 9): 3681-3696.[citado 2025 dez. 01 ] Available from: https://observatorio.fm.usp.br/handle/OPI/55937
Artigo de periodico
Effects of Ticagrelor and Clopidogrel on Coronary Microcirculation in Patients with Acute Myocardial Infarction (2022)
Scanavini-Filho, Marco Antonio; Berwanger, Otavio; Matthias, Wilson; Aguiar, Miguel O.; Chiang, Hsu P.; Azevedo, Luciene; Baracioli, Luciano M.; Lima, Felipe G.; Furtado, Remo H. M.; Dalcoquio, Talia F.; Nicolau, Jose Carlos
Fonte: Advances in therapy. Unidade: FM
Assuntos: INFARTO DO MIOCÁRDIO, DIAGNÓSTICO POR IMAGEM, FARMACOTERAPIA, AGREGAÇÃO PLAQUETÁRIA, FÁRMACOS (SISTEMA CARDIOVASCULAR)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SCANAVINI-FILHO, Marco Antonio et al. Effects of Ticagrelor and Clopidogrel on Coronary Microcirculation in Patients with Acute Myocardial Infarction. Advances in therapy, v. 39, n. 4, p. 1832-1843, 2022Tradução . . Disponível em: https://doi.org/10.1007/s12325-022-02061-0. Acesso em: 01 dez. 2025.
APA
Scanavini-Filho, M. A., Berwanger, O., Matthias, W., Aguiar, M. O., Chiang, H. P., Azevedo, L., et al. (2022). Effects of Ticagrelor and Clopidogrel on Coronary Microcirculation in Patients with Acute Myocardial Infarction. Advances in therapy, 39( 4), 1832-1843. doi:10.1007/s12325-022-02061-0
NLM
Scanavini-Filho MA, Berwanger O, Matthias W, Aguiar MO, Chiang HP, Azevedo L, Baracioli LM, Lima FG, Furtado RHM, Dalcoquio TF, Nicolau JC. Effects of Ticagrelor and Clopidogrel on Coronary Microcirculation in Patients with Acute Myocardial Infarction [Internet]. Advances in therapy. 2022 ; 39( 4): 1832-1843.[citado 2025 dez. 01 ] Available from: https://doi.org/10.1007/s12325-022-02061-0
Vancouver
Scanavini-Filho MA, Berwanger O, Matthias W, Aguiar MO, Chiang HP, Azevedo L, Baracioli LM, Lima FG, Furtado RHM, Dalcoquio TF, Nicolau JC. Effects of Ticagrelor and Clopidogrel on Coronary Microcirculation in Patients with Acute Myocardial Infarction [Internet]. Advances in therapy. 2022 ; 39( 4): 1832-1843.[citado 2025 dez. 01 ] Available from: https://doi.org/10.1007/s12325-022-02061-0
Artigo de periodico
Long-term safety, tolerability and survival in patients with pulmonary arterial hypertension treated with macitentan: results from the SERAPHIN open-label extension (2022)
Souza, Rogerio de ; Delcroix, Marion; Galie, Nazzareno; Jansa, Pavel; Mehta, Sanjay; Pulido, Tomas; Rubin, Lewis; Sastry, B. K. S; Simonneau, Gerald; Sitbon, Olivier
Fonte: Advances in therapy. Unidade: FM
Assuntos: ESTUDOS RANDOMIZADOS, HIPERTENSÃO PULMONAR, TERAPIA COMBINADA, SOBREVIDA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, Rogerio de et al. Long-term safety, tolerability and survival in patients with pulmonary arterial hypertension treated with macitentan: results from the SERAPHIN open-label extension. Advances in therapy, v. 39, n. 9, p. 4374-4390, 2022Tradução . . Disponível em: https://doi.org/10.1007/s12325-022-02199-x. Acesso em: 01 dez. 2025.
APA
Souza, R. de, Delcroix, M., Galie, N., Jansa, P., Mehta, S., Pulido, T., et al. (2022). Long-term safety, tolerability and survival in patients with pulmonary arterial hypertension treated with macitentan: results from the SERAPHIN open-label extension. Advances in therapy, 39( 9), 4374-4390. doi:10.1007/s12325-022-02199-x
NLM
Souza R de, Delcroix M, Galie N, Jansa P, Mehta S, Pulido T, Rubin L, Sastry BKS, Simonneau G, Sitbon O. Long-term safety, tolerability and survival in patients with pulmonary arterial hypertension treated with macitentan: results from the SERAPHIN open-label extension [Internet]. Advances in therapy. 2022 ; 39( 9): 4374-4390.[citado 2025 dez. 01 ] Available from: https://doi.org/10.1007/s12325-022-02199-x
Vancouver
Souza R de, Delcroix M, Galie N, Jansa P, Mehta S, Pulido T, Rubin L, Sastry BKS, Simonneau G, Sitbon O. Long-term safety, tolerability and survival in patients with pulmonary arterial hypertension treated with macitentan: results from the SERAPHIN open-label extension [Internet]. Advances in therapy. 2022 ; 39( 9): 4374-4390.[citado 2025 dez. 01 ] Available from: https://doi.org/10.1007/s12325-022-02199-x
Artigo de periodico
The Selective Role of Open and Endoscopic Approaches for Sinonasal Malignant Tumours (2022)
Lopez, Fernando; Shah, Jatin P; Beitler, Jonathan J; Snyderman, Carl H; Lund, Valerie; Piazza, Cesare; Makitie, Antti A; Guntinas-Lichius, Orlando; Rodrigo, Juan P; Kowalski, Luiz Paulo
Fonte: Advances in therapy. Unidade: FM
Assuntos: NEOPLASIAS NASAIS, RECIDIVA LOCAL DE NEOPLASIA, TERAPIAS COMPLEMENTARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LOPEZ, Fernando et al. The Selective Role of Open and Endoscopic Approaches for Sinonasal Malignant Tumours. Advances in therapy, v. 39, n. 6, p. 2379-2397, 2022Tradução . . Disponível em: https://doi.org/10.1007/s12325-022-02080-x. Acesso em: 01 dez. 2025.
APA
Lopez, F., Shah, J. P., Beitler, J. J., Snyderman, C. H., Lund, V., Piazza, C., et al. (2022). The Selective Role of Open and Endoscopic Approaches for Sinonasal Malignant Tumours. Advances in therapy, 39( 6), 2379-2397. doi:10.1007/s12325-022-02080-x
NLM
Lopez F, Shah JP, Beitler JJ, Snyderman CH, Lund V, Piazza C, Makitie AA, Guntinas-Lichius O, Rodrigo JP, Kowalski LP. The Selective Role of Open and Endoscopic Approaches for Sinonasal Malignant Tumours [Internet]. Advances in therapy. 2022 ; 39( 6): 2379-2397.[citado 2025 dez. 01 ] Available from: https://doi.org/10.1007/s12325-022-02080-x
Vancouver
Lopez F, Shah JP, Beitler JJ, Snyderman CH, Lund V, Piazza C, Makitie AA, Guntinas-Lichius O, Rodrigo JP, Kowalski LP. The Selective Role of Open and Endoscopic Approaches for Sinonasal Malignant Tumours [Internet]. Advances in therapy. 2022 ; 39( 6): 2379-2397.[citado 2025 dez. 01 ] Available from: https://doi.org/10.1007/s12325-022-02080-x
Artigo de periodico
Benign peripheral non-cranial nerve sheath tumors of the neck (2022)
Suarez, Carlos; Lopez, Fernando; Rodrigo, Juan P; Mendenhall, William M; Bree, Remco de; Makitie, Antti A; Poorten, Vincent Vander; Takes, Robert P; Bondi, Stefano; Kowalski, Luiz Paulo
Fonte: Advances in therapy. Unidade: FM
Assuntos: NEOPLASIAS DE CABEÇA E PESCOÇO, NERVOS PERIFÉRICOS, CIRURGIA VIDEOASSISTIDA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SUAREZ, Carlos et al. Benign peripheral non-cranial nerve sheath tumors of the neck. Advances in therapy, v. 39, n. 8, p. 3449-3471, 2022Tradução . . Disponível em: https://doi.org/10.1007/s12325-022-02191-5. Acesso em: 01 dez. 2025.
APA
Suarez, C., Lopez, F., Rodrigo, J. P., Mendenhall, W. M., Bree, R. de, Makitie, A. A., et al. (2022). Benign peripheral non-cranial nerve sheath tumors of the neck. Advances in therapy, 39( 8), 3449-3471. doi:10.1007/s12325-022-02191-5
NLM
Suarez C, Lopez F, Rodrigo JP, Mendenhall WM, Bree R de, Makitie AA, Poorten VV, Takes RP, Bondi S, Kowalski LP. Benign peripheral non-cranial nerve sheath tumors of the neck [Internet]. Advances in therapy. 2022 ; 39( 8): 3449-3471.[citado 2025 dez. 01 ] Available from: https://doi.org/10.1007/s12325-022-02191-5
Vancouver
Suarez C, Lopez F, Rodrigo JP, Mendenhall WM, Bree R de, Makitie AA, Poorten VV, Takes RP, Bondi S, Kowalski LP. Benign peripheral non-cranial nerve sheath tumors of the neck [Internet]. Advances in therapy. 2022 ; 39( 8): 3449-3471.[citado 2025 dez. 01 ] Available from: https://doi.org/10.1007/s12325-022-02191-5
Artigo de periodico
Influence of Direct Thrombin Inhibitor and Low Molecular Weight Heparin on Platelet Function in Patients with Coronary Artery Disease: a Prospective Interventional Trial (2020)
Arantes, Flavia B. B; Menezes, Fernando R; Franci, Andre; Barbosa, Carlos J. D. G; Dalcoquio, Talia F; Nakashima, Carlos A. K; Baracioli, Luciano M; Ramires, José Antônio Franchini ; Kalil Filho, Roberto ; Nicolau, José Carlos
Fonte: Advances in therapy. Unidade: FM
Assuntos: ENVELHECIMENTO, AGREGAÇÃO PLAQUETÁRIA, ESTUDOS PROSPECTIVOS, MEIA IDADE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ARANTES, Flavia B. B et al. Influence of Direct Thrombin Inhibitor and Low Molecular Weight Heparin on Platelet Function in Patients with Coronary Artery Disease: a Prospective Interventional Trial. Advances in therapy, v. 37, n. 1, p. 420-430, 2020Tradução . . Disponível em: https://doi.org/10.1007/s12325-019-01153-8. Acesso em: 01 dez. 2025.
APA
Arantes, F. B. B., Menezes, F. R., Franci, A., Barbosa, C. J. D. G., Dalcoquio, T. F., Nakashima, C. A. K., et al. (2020). Influence of Direct Thrombin Inhibitor and Low Molecular Weight Heparin on Platelet Function in Patients with Coronary Artery Disease: a Prospective Interventional Trial. Advances in therapy, 37( 1), 420-430. doi:10.1007/s12325-019-01153-8
NLM
Arantes FBB, Menezes FR, Franci A, Barbosa CJDG, Dalcoquio TF, Nakashima CAK, Baracioli LM, Ramires JAF, Kalil Filho R, Nicolau JC. Influence of Direct Thrombin Inhibitor and Low Molecular Weight Heparin on Platelet Function in Patients with Coronary Artery Disease: a Prospective Interventional Trial [Internet]. Advances in therapy. 2020 ; 37( 1): 420-430.[citado 2025 dez. 01 ] Available from: https://doi.org/10.1007/s12325-019-01153-8
Vancouver
Arantes FBB, Menezes FR, Franci A, Barbosa CJDG, Dalcoquio TF, Nakashima CAK, Baracioli LM, Ramires JAF, Kalil Filho R, Nicolau JC. Influence of Direct Thrombin Inhibitor and Low Molecular Weight Heparin on Platelet Function in Patients with Coronary Artery Disease: a Prospective Interventional Trial [Internet]. Advances in therapy. 2020 ; 37( 1): 420-430.[citado 2025 dez. 01 ] Available from: https://doi.org/10.1007/s12325-019-01153-8
Artigo de periodico
Real-world outcomes with lomitapide use in paediatric patients with homozygous familial hypercholesterolaemia (2019)
Ben-omran, Tawfeg; Masana, Luis; Kolovou, Genovefa; Ariceta, Gema; Novoa, F. Javier; Lund, Allan M; Bogsrud, Martin P; Araujo, Maria; Hussein, Osamah; Santos Filho, Raul Dias dos
Fonte: Advances in therapy. Unidade: FM
Assuntos: CARDIOLOGIA, LIPOPROTEÍNAS, PEDIATRIA, HIPERCOLESTEROLEMIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BEN-OMRAN, Tawfeg et al. Real-world outcomes with lomitapide use in paediatric patients with homozygous familial hypercholesterolaemia. Advances in therapy, v. 36, n. 7, p. 1786-1811, 2019Tradução . . Disponível em: https://doi.org/10.1007/s12325-019-00985-8. Acesso em: 01 dez. 2025.
APA
Ben-omran, T., Masana, L., Kolovou, G., Ariceta, G., Novoa, F. J., Lund, A. M., et al. (2019). Real-world outcomes with lomitapide use in paediatric patients with homozygous familial hypercholesterolaemia. Advances in therapy, 36( 7), 1786-1811. doi:10.1007/s12325-019-00985-8
NLM
Ben-omran T, Masana L, Kolovou G, Ariceta G, Novoa FJ, Lund AM, Bogsrud MP, Araujo M, Hussein O, Santos Filho RD dos. Real-world outcomes with lomitapide use in paediatric patients with homozygous familial hypercholesterolaemia [Internet]. Advances in therapy. 2019 ; 36( 7): 1786-1811.[citado 2025 dez. 01 ] Available from: https://doi.org/10.1007/s12325-019-00985-8
Vancouver
Ben-omran T, Masana L, Kolovou G, Ariceta G, Novoa FJ, Lund AM, Bogsrud MP, Araujo M, Hussein O, Santos Filho RD dos. Real-world outcomes with lomitapide use in paediatric patients with homozygous familial hypercholesterolaemia [Internet]. Advances in therapy. 2019 ; 36( 7): 1786-1811.[citado 2025 dez. 01 ] Available from: https://doi.org/10.1007/s12325-019-00985-8
Artigo de periodico
Cardiac and Hemodynamic Benefits: Mode of Action of Ivabradine in Heart Failure (2015)
Pereira-Barretto, Antonio Carlos
Fonte: Advances in therapy. Unidade: FM
Assuntos: HEMODINÂMICA, DOENÇAS CARDIOVASCULARES, FÁRMACOS (SISTEMA CARDIOVASCULAR)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEREIRA-BARRETTO, Antonio Carlos. Cardiac and Hemodynamic Benefits: Mode of Action of Ivabradine in Heart Failure. Advances in therapy, v. 32, n. 10, p. 906-919, 2015Tradução . . Disponível em: http://link.springer.com/article/10.1007%2Fs12325-015-0257-6. Acesso em: 01 dez. 2025.
APA
Pereira-Barretto, A. C. (2015). Cardiac and Hemodynamic Benefits: Mode of Action of Ivabradine in Heart Failure. Advances in therapy, 32( 10), 906-919. doi:10.1007/s12325-015-0257-6
NLM
Pereira-Barretto AC. Cardiac and Hemodynamic Benefits: Mode of Action of Ivabradine in Heart Failure [Internet]. Advances in therapy. 2015 ; 32( 10): 906-919.[citado 2025 dez. 01 ] Available from: http://link.springer.com/article/10.1007%2Fs12325-015-0257-6
Vancouver
Pereira-Barretto AC. Cardiac and Hemodynamic Benefits: Mode of Action of Ivabradine in Heart Failure [Internet]. Advances in therapy. 2015 ; 32( 10): 906-919.[citado 2025 dez. 01 ] Available from: http://link.springer.com/article/10.1007%2Fs12325-015-0257-6

Unidades USP

ReP

Filtros

Autores

Autores USP

Ano de publicação

Assuntos

Afiliação dos autores externos não normalizada

País das instituições de afiliação dos autores externos